However, the literature varies with respect to IDO1 loss or inhibition, with both positive and negative results reported in colitis: IDO1-deficient mice are less sensitive to DSS colitis [33], yet mice treated with both IDO1 stimulation and IDO1 inhibitor combined, lose the protective effect of IDO1 stimulation [32]. Here, IDO1 is linked to colitis.